Search alternatives:
concern » concerns (Expand Search)
decrease » increase (Expand Search)
Showing 1 - 20 results of 120 for search '(( significant concern disease ) OR ( significantly linked decrease ))', query time: 0.10s Refine Results
  1. 1
  2. 2

    An assessment of the level of concern among hospital-based health-care workers regarding MERS outbreaks in Saudi Arabia by Abolfotouh, Mostafa A.

    Published 2017
    “…Methods An anonymous, self-administered, previously validated questionnaire was given to 1031 HCWs at three tertiary hospitals in Saudi Arabia from October to December, 2014. Concerns regarding the disease, its severity and governmental efforts to contain it, as well as disease outcomes were assessed using 31 concern statements in five distinct domains. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  3. 3

    Antifungal potential of plant-based extracts against <i>Candida</i> species: values, safety concerns, and possible applications by Atefeh Esmaeili (462337)

    Published 2025
    “…<p dir="ltr">Fungal infections have emerged as a significant global health concern, with <i>Candida</i> species, opportunistic yeasts living symbiotically in various parts of the human body, playing a major role in pathogenic invasions. …”
  4. 4
  5. 5

    In-Hospital Outcomes and Temporal Trends of Surgical Versus Intravascular Ultrasound–Guided Endovascular Interventions for Femoropopliteal Disease by Elsayed, Basel

    Published 2025
    “…BackgroundPeripheral artery disease is a global health concern, with femoropopliteal disease being a common manifestation. …”
    Get full text
    Get full text
    Get full text
    article
  6. 6
  7. 7

    Classification and segmentation of kidney MRI images for chronic kidney disease detection by Md. Sakib Bin Islam (20494559)

    Published 2024
    “…<p>Chronic Kidney Disease (CKD) is a common ailment with significant public health implications, underscoring the critical importance of early detection and diagnosis for effective management. …”
  8. 8
  9. 9

    Anti-amyloid monoclonal antibody therapies in Alzheimer’s disease – a scoping review by Shahd Abubaker Elamin (22569539)

    Published 2025
    “…<p dir="ltr">Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting millions worldwide, and with advancements in the medical field, Anti-amyloid monoclonal antibodies (AA mAbs) targeting amyloid-β have emerged as potential disease-modifying agents altering AD pathology. …”
  10. 10
  11. 11

    Prevalence of iron overload in patients with chronic kidney disease on peritoneal dialysis: A scoping review by Abdulqadir J. Nashwan (11659453)

    Published 2024
    “…<h3>Background and Aims</h3><p dir="ltr">Chronic kidney disease (CKD) patients undergoing peritoneal dialysis (PD) are susceptible to complications, including iron overload, which can significantly impact their prognosis and overall health. …”
  12. 12

    Advances in Huntington’s Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review by Sarah Aqel (17787809)

    Published 2025
    “…<p dir="ltr">Neurodegenerative disorders (NDs) cause progressive neuronal loss and are a significant public health concern, with NDs projected to become the second leading global cause of death within two decades. …”
  13. 13

    Isolated pulmonary cryptococcosis in a patient with Crohn's disease treated with infliximab: A case report and literature review by Mousa Hussein (14137052)

    Published 2021
    “…However, increased risk of infections is one of the most important concerns associated with these agents. Reactivation of tuberculosis and fungal infections have emerged as significant infective complications of anti-TNF-α therapy. …”
  14. 14
  15. 15

    A young patient with Graves' disease presenting with a triad of heart failure, pancytopenia, and jaundice: A case report by Mohamed Kamal Sabra (17075230)

    Published 2024
    “…</p><p dir="ltr">Graves' disease causes a large spectrum of clinical manifestations. …”
  16. 16

    Validation of Polygenic Risk Scores for Coronary Heart Disease in a Middle Eastern Cohort Using Whole Genome Sequencing by Mohamad Saad (214545)

    Published 2022
    “…<h3>Background</h3><p dir="ltr">Enthusiasm for using polygenic risk scores (PRSs) in clinical practice is tempered by concerns about their portability to diverse ancestry groups, thus motivating genome-wide association studies in non-European ancestry cohorts.…”
  17. 17

    Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study by Ayman Al-Dahshan (8962568)

    Published 2020
    “…<h3>Background </h3><p dir="ltr">Polypharmacy has become a global public health concern particularly in the elderly population. The elderly population is the most susceptible to the negative effects of polypharmacy due to their altered pharmacokinetics and decreased drug clearance. …”
  18. 18

    Correction: Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study by Ayman Al-Dahshan (8962568)

    Published 2020
    “…<p dir="ltr">Correction to: Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study. …”
  19. 19

    Evaluation of psychological distress, burnout and structural empowerment status of healthcare workers during the outbreak of coronavirus disease (COVID-19): a cross-sectional quest... by Sara Taleb (11264352)

    Published 2024
    “…<h3>Background</h3><p dir="ltr">In light of several recent studies, there is evidence that the coronavirus disease 2019 (COVID-19) pandemic has caused various mental health concerns in the general population, as well as among healthcare workers (HCWs). …”
  20. 20

    Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-... by Mohamed Yassin (4166515)

    Published 2025
    “…<p>This systematic review aims to summarise the clinical outcomes of l-glutamine, crizanlizumab, and voxelotor in the treatment of sickle cell disease (SCD) based on clinical trials and real-world data and to identify any gaps in the observations. …”